in pursuit of better
A doctor and a businessman reconnect at a high school reunion, and naturally, they talk shop.
Physician Charlie Birbara and entrepreneur Milt Peterson realized they shared a vision of helping people who suffered from debilitating conditions. Together with entrepreneur Rick Peterson and scientist Philip Birbara, they formed a founding team that brought decades of individual success and complementary talents. The team’s shared vision was to build a respected and successful pharmaceutical company that would bring real benefit to others.
They laid a vital cornerstone of that vision by convincing John Walker, a pharmaceutical visionary, to add his brilliance to the effort. John in turn assembled a team of veteran pharmaceutical executives who quickly brought one osteoarthritis (OA) pain product, over-the-counter PainBloc24® (0.25% capsaicin), to market and then created a robust pipeline of promising pharmaceutical drug candidates.
That pipeline of candidates has now been spun off into a new dedicated pharmaceutical organization, Propella Therapeutics. The creation of Propella focuses financial investment and management expertise on the rapid advancement of these products by leveraging the 505 (b) (2) drug approval process.